Sunrest Lifescience Limited (NSE:SUNREST)

India · Delayed Price · Currency is INR

41.00

-1.15 (-2.73%)

Aug 21, 2026, 2:55 PM IST

-18.16% (1Y)

Market Cap	175.94M -18.2%
Revenue (ttm)	708.33M +112.0%
Net Income	41.16M +105.3%
EPS	9.59 +105.4%
Shares Out	4.29M
PE Ratio	4.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,600
Open	41.00
Previous Close	42.15
Day's Range	40.00 - 41.00
52-Week Range	29.55 - 54.00
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of dist... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 2017

Employees 210

Stock Exchange National Stock Exchange of India

Ticker Symbol SUNREST

Full Company Profile

Financial Performance

In fiscal year 2026, Sunrest Lifescience's revenue was 708.33 million, an increase of 111.99% compared to the previous year's 334.13 million. Earnings were 41.16 million, an increase of 105.27%.

Financial Statements